Literature DB >> 9114796

Role of endogenous somatostatin in postprandial hypersecretion of neurotensin in patients after gastrectomy.

T Sakamoto1, M Miyata, M Izukura, Y Tanaka, K Iwase, S Imabun, H Matsuda.   

Abstract

OBJECTIVE: The purpose of this report is to elucidate the mechanism of the hypersecretion of neurotensin (NT) after gastrectomy. SUMMARY BACKGROUND DATA: NT secretion induced by fat ingestion is increased after pancreatoduodenectomy or distal gastrectomy. The hypersecretion of NT in the patients undergoing resection of the upper gastrointestinal tract is suppressed by an exogenous somatostatin (SST) analog.
METHODS: We observed simultaneously the secretion of NT and SST in the same patients before and after gastrectomy (n = 7). We also observed the secretion of these hormones induced by intraduodenal (ID) fat infusion in the normal volunteers (n = 6).
RESULTS: The response of plasma NT to fat ingestion was significantly increased after gastrectomy compared with that before gastrectomy. The response of plasma SST after gastrectomy was significantly suppressed. The response of plasma NT and SST after ID fat infusion in the normal volunteers was similar to the gastrectomized state.
CONCLUSION: Diminution of SST secretion, probably caused by the lack of SST cells in the distal part of the stomach, may play a role in augmenting NT secretion after gastrectomy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9114796      PMCID: PMC1190745          DOI: 10.1097/00000658-199704000-00006

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  10 in total

1.  Malnutrition after gastric surgery. Association with exaggerated distal intestinal hormone release.

Authors:  D P Kotler; D Sherman; S R Bloom; P R Holt
Journal:  Dig Dis Sci       Date:  1985-03       Impact factor: 3.199

2.  Diurnal profile of plasma somatostatin in man.

Authors:  P G Burhol; R Jorde; T G Jenssen; I Lygren; J Florholmen
Journal:  Acta Physiol Scand       Date:  1984-01

3.  Simple extraction method and radioimmunoassay for somatostatin in human plasma.

Authors:  T L Peeters; Y Depraetere; G R Vantrappen
Journal:  Clin Chem       Date:  1981-06       Impact factor: 8.327

4.  An effect of somatostatin on neurotensin secretion.

Authors:  T Sakamoto; M Miyata; T Emoto; M Izukura; K Iwase; S Mizutani; H Matsuda
Journal:  Regul Pept       Date:  1995-04-14

5.  Inhibition of neurotensin release by a cyclic hexapeptide analog of somatostatin.

Authors:  C F Ferris; M C Parker; M J Armstrong; S E Leeman
Journal:  Peptides       Date:  1985 Sep-Oct       Impact factor: 3.750

6.  Neurotensin-like immunoreactivity after intestinal resection in the rat.

Authors:  P S Olsen; J H Pedersen; S S Poulsen; Y Yamashita; P Kirkegaard
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

7.  Neurotensin regulates growth of human pancreatic cancer.

Authors:  J Ishizuka; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

8.  Neurotensin stimulates growth of colon cancer.

Authors:  K Yoshinaga; B M Evers; M Izukura; D Parekh; T Uchida; C M Townsend; J C Thompson
Journal:  Surg Oncol       Date:  1992-04       Impact factor: 3.279

9.  Somatostatin as a mediator of the effect of neurotensin on pentagastrin-stimulated acid secretion in rats.

Authors:  R A Hammer; A Ochoa; C Fernandez; A Ertan; A Arimura
Journal:  Peptides       Date:  1992 Nov-Dec       Impact factor: 3.750

10.  Neurotensin induces hyperplasia of the pancreas and growth of the gastric antrum in rats.

Authors:  G E Feurle; B Müller; E Rix
Journal:  Gut       Date:  1987       Impact factor: 23.059

  10 in total
  1 in total

1.  Pancreatic and peripancreatic somatostatinomas.

Authors:  J M L Williamson; C C Thorn; D Spalding; R C N Williamson
Journal:  Ann R Coll Surg Engl       Date:  2011-07       Impact factor: 1.891

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.